Jonas Daniel S's Form 4 filing
CONMED Corp (CNMD) · filed Sep 17, 2021
- Accession no.
- 0001127602-21-025507
- Filed
- Sep 17, 2021
- Trade date
- Sep 15, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $427.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jonas Daniel SCIK 0001238334 | Officer (EVP Legal Affairs,Gen. Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2021 | Common Stock | SSaleDisposed | −3,357 | $127.26F1 | −$427,211.82 | 10,464 | Direct | |
| Sep 15, 2021 | Common Stock | MOption exerciseAcquired | +11,000 | $59.96 | +$659,560 | 21,464 | Direct | |
| Sep 15, 2021 | Common Stock | FTax withholdingDisposed | −8,327 | $127.56 | −$1,062,192.12 | 13,137 | Direct | |
| Sep 15, 2021 | Common Stock | GGiftDisposed | −1,000 | $0.00 | $0 | 12,137 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2021 | Common Stock | MOption exerciseDisposed | −11,000 | $0.00 | $0 | 11,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.20 to $127.265. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Referenced by the price of 1 transaction in Table I.